Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Pediatric Hematology/Oncology
General Hepatology
Questions discussed in this category
In a patient with recurrent fibrolamellar HCC a year after upfront resection (previously refused adjuvant therapy) with a solitary abdominal mass, would you offer neoadjuvant therapy to assess response?
Or offer resection followed by adjuvant therapy?
2 Answers available
How do you approach relapsed hepatocellular malignant neoplasm NOS after transplant in pediatric or AYA patients?
2 Answers available
What would be your next line of treatment for disease control in a pediatric patient with metastatic hepatocellular carcinoma in partial response after multiple therapies?
The patient already received PLADO+sorafenib, Y90, and Atezolizumab/Bevacizumab complicated by recurrent episodes of bleeding from esophageal varices....
2 Answers available
How do you approach treatment of metastatic hepatocellular carcinoma in an adolescent?
Would you offer liver transplant in the setting of metastatic disease?
1 Answer available
17373
10017
11946
10405
Related Topics in Pediatric Hematology/Oncology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers